nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—ABCC10—Methotrexate—ankylosing spondylitis	0.0833	0.0968	CbGbCtD
Etoposide—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0594	0.069	CbGbCtD
Etoposide—PTGS2—Triamcinolone—ankylosing spondylitis	0.0587	0.0682	CbGbCtD
Etoposide—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0587	0.0682	CbGbCtD
Etoposide—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0537	0.0624	CbGbCtD
Etoposide—ABCC3—Methotrexate—ankylosing spondylitis	0.0524	0.0609	CbGbCtD
Etoposide—PTGS2—Betamethasone—ankylosing spondylitis	0.0503	0.0585	CbGbCtD
Etoposide—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0495	0.0576	CbGbCtD
Etoposide—ABCC1—Methotrexate—ankylosing spondylitis	0.0322	0.0374	CbGbCtD
Etoposide—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0297	0.0346	CbGbCtD
Etoposide—ABCC2—Dexamethasone—ankylosing spondylitis	0.0296	0.0344	CbGbCtD
Etoposide—PTGS2—Dexamethasone—ankylosing spondylitis	0.0293	0.034	CbGbCtD
Etoposide—ABCG2—Dexamethasone—ankylosing spondylitis	0.0268	0.0311	CbGbCtD
Etoposide—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0255	0.0297	CbGbCtD
Etoposide—ABCC2—Methotrexate—ankylosing spondylitis	0.0238	0.0277	CbGbCtD
Etoposide—ABCG2—Methotrexate—ankylosing spondylitis	0.0215	0.025	CbGbCtD
Etoposide—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0191	0.0222	CbGbCtD
Etoposide—ABCB1—Betamethasone—ankylosing spondylitis	0.0166	0.0193	CbGbCtD
Etoposide—ABCB1—Prednisolone—ankylosing spondylitis	0.0164	0.019	CbGbCtD
Etoposide—ABCB1—Prednisone—ankylosing spondylitis	0.0155	0.018	CbGbCtD
Etoposide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0153	0.0178	CbGbCtD
Etoposide—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0148	0.0172	CbGbCtD
Etoposide—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0143	0.0166	CbGbCtD
Etoposide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0116	0.0135	CbGbCtD
Etoposide—CYP3A4—Betamethasone—ankylosing spondylitis	0.00995	0.0116	CbGbCtD
Etoposide—CYP3A4—Prednisolone—ankylosing spondylitis	0.00981	0.0114	CbGbCtD
Etoposide—ABCB1—Dexamethasone—ankylosing spondylitis	0.00966	0.0112	CbGbCtD
Etoposide—CYP3A4—Prednisone—ankylosing spondylitis	0.00927	0.0108	CbGbCtD
Etoposide—ABCB1—Methotrexate—ankylosing spondylitis	0.00776	0.00902	CbGbCtD
Etoposide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00579	0.00673	CbGbCtD
Etoposide—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.00071	0.148	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000699	0.145	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000699	0.145	CbGdCrCtD
Etoposide—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000683	0.142	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000428	0.0892	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000422	0.0878	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000422	0.0878	CbGdCrCtD
Etoposide—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000412	0.0858	CbGdCrCtD
Etoposide—Eye disorder—Betamethasone—ankylosing spondylitis	0.000277	0.00206	CcSEcCtD
Etoposide—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000277	0.00206	CcSEcCtD
Etoposide—Back pain—Triamcinolone—ankylosing spondylitis	0.000276	0.00204	CcSEcCtD
Etoposide—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000272	0.00202	CcSEcCtD
Etoposide—Angiopathy—Betamethasone—ankylosing spondylitis	0.000269	0.002	CcSEcCtD
Etoposide—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000269	0.002	CcSEcCtD
Etoposide—Convulsion—Prednisolone—ankylosing spondylitis	0.000268	0.00199	CcSEcCtD
Etoposide—Hypertension—Prednisolone—ankylosing spondylitis	0.000267	0.00198	CcSEcCtD
Etoposide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000264	0.00196	CcSEcCtD
Etoposide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000264	0.00195	CcSEcCtD
Etoposide—Alopecia—Dexamethasone—ankylosing spondylitis	0.000262	0.00194	CcSEcCtD
Etoposide—Alopecia—Betamethasone—ankylosing spondylitis	0.000262	0.00194	CcSEcCtD
Etoposide—Discomfort—Prednisolone—ankylosing spondylitis	0.000261	0.00193	CcSEcCtD
Etoposide—Malaise—Triamcinolone—ankylosing spondylitis	0.000257	0.0019	CcSEcCtD
Etoposide—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000256	0.0019	CcSEcCtD
Etoposide—Malaise—Methylprednisolone—ankylosing spondylitis	0.000256	0.0019	CcSEcCtD
Etoposide—Vertigo—Triamcinolone—ankylosing spondylitis	0.000256	0.0019	CcSEcCtD
Etoposide—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000255	0.00189	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000253	0.00187	CcSEcCtD
Etoposide—Neutropenia—Methotrexate—ankylosing spondylitis	0.000252	0.00187	CcSEcCtD
Etoposide—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00025	0.00186	CcSEcCtD
Etoposide—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00025	0.00185	CcSEcCtD
Etoposide—Cough—Triamcinolone—ankylosing spondylitis	0.000249	0.00184	CcSEcCtD
Etoposide—Convulsion—Triamcinolone—ankylosing spondylitis	0.000247	0.00183	CcSEcCtD
Etoposide—Tachycardia—Prednisolone—ankylosing spondylitis	0.000247	0.00183	CcSEcCtD
Etoposide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000246	0.00183	CcSEcCtD
Etoposide—Hypertension—Triamcinolone—ankylosing spondylitis	0.000246	0.00182	CcSEcCtD
Etoposide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000245	0.00182	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000244	0.00181	CcSEcCtD
Etoposide—Pneumonia—Methotrexate—ankylosing spondylitis	0.000242	0.00179	CcSEcCtD
Etoposide—Eye disorder—Prednisone—ankylosing spondylitis	0.000242	0.00179	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000241	0.00178	CcSEcCtD
Etoposide—Infestation—Methotrexate—ankylosing spondylitis	0.000241	0.00178	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00024	0.00178	CcSEcCtD
Etoposide—Flushing—Prednisone—ankylosing spondylitis	0.00024	0.00178	CcSEcCtD
Etoposide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00024	0.00178	CcSEcCtD
Etoposide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00024	0.00178	CcSEcCtD
Etoposide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00024	0.00178	CcSEcCtD
Etoposide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000239	0.00177	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000239	0.00177	CcSEcCtD
Etoposide—Renal failure—Methotrexate—ankylosing spondylitis	0.000237	0.00175	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—ankylosing spondylitis	0.000235	0.00174	CcSEcCtD
Etoposide—Angiopathy—Prednisone—ankylosing spondylitis	0.000235	0.00174	CcSEcCtD
Etoposide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000234	0.00173	CcSEcCtD
Etoposide—Immune system disorder—Prednisone—ankylosing spondylitis	0.000234	0.00173	CcSEcCtD
Etoposide—Malaise—Dexamethasone—ankylosing spondylitis	0.000233	0.00173	CcSEcCtD
Etoposide—Malaise—Betamethasone—ankylosing spondylitis	0.000233	0.00173	CcSEcCtD
Etoposide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000232	0.00172	CcSEcCtD
Etoposide—Vertigo—Dexamethasone—ankylosing spondylitis	0.000232	0.00172	CcSEcCtD
Etoposide—Vertigo—Betamethasone—ankylosing spondylitis	0.000232	0.00172	CcSEcCtD
Etoposide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000232	0.00172	CcSEcCtD
Etoposide—Infection—Triamcinolone—ankylosing spondylitis	0.000231	0.00171	CcSEcCtD
Etoposide—Infection—Methylprednisolone—ankylosing spondylitis	0.00023	0.00171	CcSEcCtD
Etoposide—Alopecia—Prednisone—ankylosing spondylitis	0.000228	0.00169	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000228	0.00169	CcSEcCtD
Etoposide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000227	0.00168	CcSEcCtD
Etoposide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000227	0.00168	CcSEcCtD
Etoposide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000227	0.00168	CcSEcCtD
Etoposide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000227	0.00168	CcSEcCtD
Etoposide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000226	0.00168	CcSEcCtD
Etoposide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000225	0.00167	CcSEcCtD
Etoposide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000225	0.00167	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000225	0.00166	CcSEcCtD
Etoposide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000224	0.00166	CcSEcCtD
Etoposide—Convulsion—Betamethasone—ankylosing spondylitis	0.000224	0.00166	CcSEcCtD
Etoposide—Convulsion—Dexamethasone—ankylosing spondylitis	0.000224	0.00166	CcSEcCtD
Etoposide—Hypertension—Dexamethasone—ankylosing spondylitis	0.000223	0.00165	CcSEcCtD
Etoposide—Hypertension—Betamethasone—ankylosing spondylitis	0.000223	0.00165	CcSEcCtD
Etoposide—Discomfort—Betamethasone—ankylosing spondylitis	0.000217	0.00161	CcSEcCtD
Etoposide—Discomfort—Dexamethasone—ankylosing spondylitis	0.000217	0.00161	CcSEcCtD
Etoposide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000217	0.00161	CcSEcCtD
Etoposide—Pain—Prednisolone—ankylosing spondylitis	0.000216	0.0016	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000213	0.00158	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000212	0.00157	CcSEcCtD
Etoposide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000211	0.00156	CcSEcCtD
Etoposide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000211	0.00156	CcSEcCtD
Etoposide—Infection—Betamethasone—ankylosing spondylitis	0.00021	0.00155	CcSEcCtD
Etoposide—Infection—Dexamethasone—ankylosing spondylitis	0.00021	0.00155	CcSEcCtD
Etoposide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000209	0.00155	CcSEcCtD
Etoposide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000209	0.00155	CcSEcCtD
Etoposide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000208	0.00154	CcSEcCtD
Etoposide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000208	0.00154	CcSEcCtD
Etoposide—Anaemia—Prednisone—ankylosing spondylitis	0.000208	0.00154	CcSEcCtD
Etoposide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000207	0.00154	CcSEcCtD
Etoposide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000207	0.00153	CcSEcCtD
Etoposide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000207	0.00153	CcSEcCtD
Etoposide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000206	0.00153	CcSEcCtD
Etoposide—Tachycardia—Betamethasone—ankylosing spondylitis	0.000206	0.00153	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000204	0.00151	CcSEcCtD
Etoposide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000204	0.00151	CcSEcCtD
Etoposide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000204	0.00151	CcSEcCtD
Etoposide—Malaise—Prednisone—ankylosing spondylitis	0.000203	0.0015	CcSEcCtD
Etoposide—Vertigo—Prednisone—ankylosing spondylitis	0.000202	0.0015	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—ankylosing spondylitis	0.000202	0.0015	CcSEcCtD
Etoposide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000201	0.00149	CcSEcCtD
Etoposide—Anorexia—Betamethasone—ankylosing spondylitis	0.000201	0.00149	CcSEcCtD
Etoposide—Urticaria—Prednisolone—ankylosing spondylitis	0.000201	0.00149	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000201	0.00149	CcSEcCtD
Etoposide—Fatigue—Triamcinolone—ankylosing spondylitis	0.0002	0.00149	CcSEcCtD
Etoposide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.0002	0.00148	CcSEcCtD
Etoposide—Pain—Triamcinolone—ankylosing spondylitis	0.000199	0.00147	CcSEcCtD
Etoposide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000198	0.00147	CcSEcCtD
Etoposide—Hypotension—Betamethasone—ankylosing spondylitis	0.000197	0.00146	CcSEcCtD
Etoposide—Hypotension—Dexamethasone—ankylosing spondylitis	0.000197	0.00146	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—ankylosing spondylitis	0.000196	0.00145	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000195	0.00145	CcSEcCtD
Etoposide—Convulsion—Prednisone—ankylosing spondylitis	0.000195	0.00145	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000195	0.00144	CcSEcCtD
Etoposide—Hypertension—Prednisone—ankylosing spondylitis	0.000194	0.00144	CcSEcCtD
Etoposide—Chills—Methotrexate—ankylosing spondylitis	0.000194	0.00144	CcSEcCtD
Etoposide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000192	0.00142	CcSEcCtD
Etoposide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000191	0.00142	CcSEcCtD
Etoposide—Alopecia—Methotrexate—ankylosing spondylitis	0.000191	0.00142	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00019	0.00141	CcSEcCtD
Etoposide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00019	0.00141	CcSEcCtD
Etoposide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000189	0.0014	CcSEcCtD
Etoposide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000189	0.0014	CcSEcCtD
Etoposide—Discomfort—Prednisone—ankylosing spondylitis	0.000189	0.0014	CcSEcCtD
Etoposide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000186	0.00138	CcSEcCtD
Etoposide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000185	0.00137	CcSEcCtD
Etoposide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000184	0.00137	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000184	0.00137	CcSEcCtD
Etoposide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000184	0.00136	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000184	0.00136	CcSEcCtD
Etoposide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000183	0.00136	CcSEcCtD
Etoposide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000183	0.00136	CcSEcCtD
Etoposide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000183	0.00136	CcSEcCtD
Etoposide—Infection—Prednisone—ankylosing spondylitis	0.000182	0.00135	CcSEcCtD
Etoposide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000182	0.00135	CcSEcCtD
Etoposide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000182	0.00135	CcSEcCtD
Etoposide—Back pain—Methotrexate—ankylosing spondylitis	0.000182	0.00135	CcSEcCtD
Etoposide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000182	0.00135	CcSEcCtD
Etoposide—Fatigue—Betamethasone—ankylosing spondylitis	0.000182	0.00135	CcSEcCtD
Etoposide—Pain—Betamethasone—ankylosing spondylitis	0.00018	0.00134	CcSEcCtD
Etoposide—Pain—Dexamethasone—ankylosing spondylitis	0.00018	0.00134	CcSEcCtD
Etoposide—Tachycardia—Prednisone—ankylosing spondylitis	0.000179	0.00133	CcSEcCtD
Etoposide—Skin disorder—Prednisone—ankylosing spondylitis	0.000178	0.00132	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000178	0.00132	CcSEcCtD
Etoposide—Anorexia—Prednisone—ankylosing spondylitis	0.000175	0.0013	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000175	0.00129	CcSEcCtD
Etoposide—Anaemia—Methotrexate—ankylosing spondylitis	0.000174	0.00129	CcSEcCtD
Etoposide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000174	0.00129	CcSEcCtD
Etoposide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000174	0.00129	CcSEcCtD
Etoposide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000172	0.00128	CcSEcCtD
Etoposide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000172	0.00128	CcSEcCtD
Etoposide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000171	0.00127	CcSEcCtD
Etoposide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000171	0.00127	CcSEcCtD
Etoposide—Malaise—Methotrexate—ankylosing spondylitis	0.00017	0.00126	CcSEcCtD
Etoposide—Vertigo—Methotrexate—ankylosing spondylitis	0.000169	0.00125	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000168	0.00125	CcSEcCtD
Etoposide—Urticaria—Betamethasone—ankylosing spondylitis	0.000168	0.00124	CcSEcCtD
Etoposide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000168	0.00124	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisone—ankylosing spondylitis	0.000167	0.0349	CbGdCrCtD
Etoposide—Dizziness—Prednisolone—ankylosing spondylitis	0.000167	0.00124	CcSEcCtD
Etoposide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000167	0.00124	CcSEcCtD
Etoposide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000167	0.00124	CcSEcCtD
Etoposide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000167	0.00124	CcSEcCtD
Etoposide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000167	0.00124	CcSEcCtD
Etoposide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000167	0.00124	CcSEcCtD
Etoposide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000166	0.00123	CcSEcCtD
Etoposide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000165	0.00122	CcSEcCtD
Etoposide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000164	0.00122	CcSEcCtD
Etoposide—Cough—Methotrexate—ankylosing spondylitis	0.000164	0.00122	CcSEcCtD
Etoposide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000164	0.00122	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.000163	0.034	CbGdCrCtD
Etoposide—Convulsion—Methotrexate—ankylosing spondylitis	0.000163	0.00121	CcSEcCtD
Etoposide—Chest pain—Methotrexate—ankylosing spondylitis	0.00016	0.00119	CcSEcCtD
Etoposide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00016	0.00118	CcSEcCtD
Etoposide—Rash—Prednisolone—ankylosing spondylitis	0.000159	0.00118	CcSEcCtD
Etoposide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000159	0.00118	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000159	0.00118	CcSEcCtD
Etoposide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000159	0.00118	CcSEcCtD
Etoposide—Fatigue—Prednisone—ankylosing spondylitis	0.000158	0.00117	CcSEcCtD
Etoposide—Headache—Prednisolone—ankylosing spondylitis	0.000158	0.00117	CcSEcCtD
Etoposide—Discomfort—Methotrexate—ankylosing spondylitis	0.000158	0.00117	CcSEcCtD
Etoposide—Constipation—Prednisone—ankylosing spondylitis	0.000157	0.00116	CcSEcCtD
Etoposide—Confusional state—Methotrexate—ankylosing spondylitis	0.000155	0.00115	CcSEcCtD
Etoposide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000154	0.00114	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000154	0.00114	CcSEcCtD
Etoposide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000153	0.00114	CcSEcCtD
Etoposide—Infection—Methotrexate—ankylosing spondylitis	0.000153	0.00113	CcSEcCtD
Etoposide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000151	0.00112	CcSEcCtD
Etoposide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000151	0.00112	CcSEcCtD
Etoposide—Asthenia—Betamethasone—ankylosing spondylitis	0.000151	0.00112	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00015	0.00111	CcSEcCtD
Etoposide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00015	0.00111	CcSEcCtD
Etoposide—Nausea—Prednisolone—ankylosing spondylitis	0.00015	0.00111	CcSEcCtD
Etoposide—Pruritus—Betamethasone—ankylosing spondylitis	0.000149	0.00111	CcSEcCtD
Etoposide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000149	0.00111	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000149	0.00111	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000148	0.0011	CcSEcCtD
Etoposide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000148	0.0011	CcSEcCtD
Etoposide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000147	0.00109	CcSEcCtD
Etoposide—Rash—Triamcinolone—ankylosing spondylitis	0.000147	0.00109	CcSEcCtD
Etoposide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000146	0.00109	CcSEcCtD
Etoposide—Anorexia—Methotrexate—ankylosing spondylitis	0.000146	0.00108	CcSEcCtD
Etoposide—Rash—Methylprednisolone—ankylosing spondylitis	0.000146	0.00108	CcSEcCtD
Etoposide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000146	0.00108	CcSEcCtD
Etoposide—Urticaria—Prednisone—ankylosing spondylitis	0.000146	0.00108	CcSEcCtD
Etoposide—Headache—Triamcinolone—ankylosing spondylitis	0.000146	0.00108	CcSEcCtD
Etoposide—Headache—Methylprednisolone—ankylosing spondylitis	0.000145	0.00108	CcSEcCtD
Etoposide—Abdominal pain—Prednisone—ankylosing spondylitis	0.000145	0.00108	CcSEcCtD
Etoposide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000145	0.00108	CcSEcCtD
Etoposide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000144	0.00107	CcSEcCtD
Etoposide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000144	0.00107	CcSEcCtD
Etoposide—Hypotension—Methotrexate—ankylosing spondylitis	0.000143	0.00106	CcSEcCtD
Etoposide—Dizziness—Betamethasone—ankylosing spondylitis	0.000139	0.00103	CcSEcCtD
Etoposide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000139	0.00103	CcSEcCtD
Etoposide—Nausea—Triamcinolone—ankylosing spondylitis	0.000138	0.00102	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000138	0.00102	CcSEcCtD
Etoposide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000138	0.00102	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000137	0.00101	CcSEcCtD
Etoposide—Somnolence—Methotrexate—ankylosing spondylitis	0.000136	0.00101	CcSEcCtD
Etoposide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000135	0.001	CcSEcCtD
Etoposide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000134	0.000994	CcSEcCtD
Etoposide—Vomiting—Betamethasone—ankylosing spondylitis	0.000134	0.000994	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000133	0.000989	CcSEcCtD
Etoposide—Rash—Betamethasone—ankylosing spondylitis	0.000133	0.000986	CcSEcCtD
Etoposide—Rash—Dexamethasone—ankylosing spondylitis	0.000133	0.000986	CcSEcCtD
Etoposide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000133	0.000985	CcSEcCtD
Etoposide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000133	0.000985	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000133	0.000982	CcSEcCtD
Etoposide—Fatigue—Methotrexate—ankylosing spondylitis	0.000132	0.000981	CcSEcCtD
Etoposide—Headache—Dexamethasone—ankylosing spondylitis	0.000132	0.000979	CcSEcCtD
Etoposide—Headache—Betamethasone—ankylosing spondylitis	0.000132	0.000979	CcSEcCtD
Etoposide—Asthenia—Prednisone—ankylosing spondylitis	0.000132	0.000977	CcSEcCtD
Etoposide—Pain—Methotrexate—ankylosing spondylitis	0.000131	0.000973	CcSEcCtD
Etoposide—Pruritus—Prednisone—ankylosing spondylitis	0.00013	0.000963	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000127	0.000938	CcSEcCtD
Etoposide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000126	0.000932	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000126	0.00093	CcSEcCtD
Etoposide—Nausea—Betamethasone—ankylosing spondylitis	0.000125	0.000929	CcSEcCtD
Etoposide—Nausea—Dexamethasone—ankylosing spondylitis	0.000125	0.000929	CcSEcCtD
Etoposide—Urticaria—Methotrexate—ankylosing spondylitis	0.000122	0.000904	CcSEcCtD
Etoposide—Dizziness—Prednisone—ankylosing spondylitis	0.000121	0.0009	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000121	0.000899	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000121	0.000899	CcSEcCtD
Etoposide—Vomiting—Prednisone—ankylosing spondylitis	0.000117	0.000866	CcSEcCtD
Etoposide—Rash—Prednisone—ankylosing spondylitis	0.000116	0.000858	CcSEcCtD
Etoposide—Dermatitis—Prednisone—ankylosing spondylitis	0.000116	0.000858	CcSEcCtD
Etoposide—Headache—Prednisone—ankylosing spondylitis	0.000115	0.000853	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000113	0.000838	CcSEcCtD
Etoposide—Asthenia—Methotrexate—ankylosing spondylitis	0.00011	0.000816	CcSEcCtD
Etoposide—Nausea—Prednisone—ankylosing spondylitis	0.000109	0.000809	CcSEcCtD
Etoposide—Pruritus—Methotrexate—ankylosing spondylitis	0.000109	0.000805	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000105	0.000778	CcSEcCtD
Etoposide—Dizziness—Methotrexate—ankylosing spondylitis	0.000102	0.000752	CcSEcCtD
Etoposide—Vomiting—Methotrexate—ankylosing spondylitis	9.76e-05	0.000723	CcSEcCtD
Etoposide—Rash—Methotrexate—ankylosing spondylitis	9.68e-05	0.000717	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—ankylosing spondylitis	9.67e-05	0.000717	CcSEcCtD
Etoposide—Headache—Methotrexate—ankylosing spondylitis	9.62e-05	0.000713	CcSEcCtD
Etoposide—Nausea—Methotrexate—ankylosing spondylitis	9.12e-05	0.000676	CcSEcCtD
